IL17A and Chagas disease: It has been demonstrated that patients with the indeterminate clinical form of Chagas disease display a predominantly modulatory immune environment, with higher production of the anti-inflammatory cytokine IL-10 [3] [4] [5] and IL-17 [6,7], which are produced by monocytes (IL-10) and T cell subsets (IL-10 and IL-17).